|
|
 |
|
|
CISDOC database
| Document ID (ISN) | 41994 |
| CIS number |
84-1000 |
| Year |
1983 |
| Convention or series no. |
DHHS (NIOSH) Publication No.84-104
|
| Title |
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, "dioxin") |
| Bibliographic information |
U.S. Department of Health and Human Services, NIOSH, Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, Ohio 45226, USA, 23 Jan. 1984. 22p. 88 ref. |
| Abstract |
In animals, TCDD causes tumorigenesis, immunological dysfunction and teratogenesis at a wide range of exposure concentrations, and evidence exists to suggest carcinogenicity. In humans, TCDD exposure has caused chloracne, metabolic disorders, e.g. porphyria, and other systemic problems. TCDD occurs as a contaminant of chlorophenols and chlorophenoxyacetic acids. TCDD should be regarded as a potential occupational carcinogen, and exposure should be controlled to the fullest extent feasible. Decontamination measures must be used for TCDD-contaminated workplaces. |
| Descriptors (primary) |
carcinogens; biological effects; tetrachlorodibenzodioxin; USA |
| Descriptors (secondary) |
phenoxyacetic acids; porphyria; directive; limitation of exposure; teratogenic effects; chloracne |
| Document type |
F - Information notes, codes of practice, standards |
| Subject(s) |
Toxic and dangerous substances
|
| Broad subject area(s) |
|
| Browse category(ies) |
Genetic factors in reaction to exposures
Heterocyclic compounds
|
|
|
|
|
|
